Search Results

There are 10739 results for: content related to: Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

  1. Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1436–1446, Dr Fred Poordad, Dr Gillian Zeldin, Dr Stuart I. Harris, Dr June Ke, Dr Limin Xu, Dr Douglas Mayers and Dr Xiao-Jian Zhou

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009337943

  2. Single-Dose and Multiple-Dose Pharmacokinetics and Safety of Telbivudine After Oral Administration in Healthy Chinese Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 999–1007, Dr Pei Hu, Dr Ji Jiang, Dr Hongyun Wang, Mr Keith Pietropaolo, Dr George C. Chao, Dr Nathaniel A. Brown and Dr Xiao-Jian Zhou

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006290623

  3. Absence of Food Effect on the Pharmacokinetics of Telbivudine Following Oral Administration in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 3, March 2006, Pages: 275–281, Xiao-Jian Zhou, Deborah M. Lloyd, George C. Chao and Nathaniel A. Brown

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270005284849

  4. Telbivudine treatment in chronic hepatitis B: experience from China

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 3–8, H. You and J. Jia

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12058

  5. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Article first published online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  6. You have full text access to this OnlineOpen article
    Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 20, Issue 4, April 2013, Pages: e37–e46, Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski and N. V. Naoumov

    Article first published online : 27 DEC 2012, DOI: 10.1111/jvh.12025

  7. You have free access to this content
    A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

    Clinical Microbiology and Infection

    Volume 20, Issue 2, February 2014, Pages: O90–O100, M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen and T.-H. Hu

    Article first published online : 10 MAY 2013, DOI: 10.1111/1469-0691.12220

  8. You have free access to this content
    Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis

    Journal of Viral Hepatitis

    Volume 17, Issue s1, March 2010, Pages: 24–33, Z. G. Wu, W. M. Yan, W. Guo, T. Chen, Y. Zou, H. W. Wang, X. J. Wang, X. J. Yang, Y. L. Lu, X. P. Luo and Q. Ning

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01268.x

  9. Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 9–17, G.-Q. Wang, Y.-P. Ding and Y.-H. Dong

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12059

  10. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 58–64, Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou and Y. Han

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12065

  11. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China

    Journal of Viral Hepatitis

    Volume 22, Issue 1, January 2015, Pages: 46–54, X. Qi, J.-Y Wang, R.-C Mao and J.-M Zhang

    Article first published online : 13 FEB 2014, DOI: 10.1111/jvh.12229

  12. You have free access to this content
    Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

    Hepatology

    Volume 47, Issue 2, February 2008, Pages: 447–454, Jinlin Hou, You-Kuan Yin, Daozhen Xu, Deming Tan, Junqi Niu, Xiaqiu Zhou, Yuming Wang, Limin Zhu, Yongwen He, Hong Ren, Mobin Wan, Chengwei Chen, Shanming Wu, Yagang Chen, Jiazhang Xu, Qinhuan Wang, Lai Wei, George Chao, Barbara Fielman Constance, George Harb, Nathaniel A. Brown and Jidong Jia

    Article first published online : 13 DEC 2007, DOI: 10.1002/hep.22075

  13. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 732–743, H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila and A. Trylesinski

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01600.x

  14. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1283–1292, Jian Sun, Qing Xie, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Rong Fan, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia and Jinlin Hou

    Article first published online : 28 FEB 2014, DOI: 10.1002/hep.26885

  15. Telbivudine therapy may shape CD4+ T-cell response to prevent liver fibrosis in patients with chronic hepatitis B

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 834–845, Jing Li, Minglei Jia, Yun Liu, Weimin She, Lei Li, Jiyao Wang and Wei Jiang

    Article first published online : 1 JUN 2014, DOI: 10.1111/liv.12589

  16. Novel anti-hepatitis B agents: a focus on telbivudine

    International Journal of Clinical Practice

    Volume 60, Issue 10, October 2006, Pages: 1295–1299, R. JONES and M. NELSON

    Article first published online : 8 SEP 2006, DOI: 10.1111/j.1742-1241.2006.01143.x

  17. You have free access to this content
    A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection

    Hepatology

    Volume 40, Issue 3, September 2004, Pages: 719–726, Ching-Lung Lai, Seng Gee Lim, Nathaniel A. Brown, Xiao-Jian Zhou, Deborah M. Lloyd, Yin-Mei Lee, Man-Fung Yuen, George C. Chao and Maureen W. Myers

    Article first published online : 30 AUG 2004, DOI: 10.1002/hep.20374

  18. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 676–684, Edward J. Gane, Yuming Wang, Yun-Fan Liaw, JinLin Hou, Satawat Thongsawat, MoBin Wan, Young M. Moon, JiDong Jia, You C. Chao, Junqi Niu, Nancy Leung, Didier Samuel, Chao Wei Hsu, Weibin Bao, Patricia Lopez and Claudio Avila

    Article first published online : 16 MAR 2011, DOI: 10.1111/j.1478-3231.2011.02490.x

  19. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26856

  20. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 860–869, Hae Rim Kim, Hyung Joon Yim, Seonghee Kang, Sang Jun Suh, Seung Young Kim, Jong Jin Hyun, Ja Seol Koo, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Sang Woo Lee, Kwan Soo Byun and Soon Ho Um

    Article first published online : 5 JUL 2014, DOI: 10.1111/liv.12605